Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Sulfuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sulfuric Acid SCHEMBL27658926 | 0.94 | — | — | |
| Sulfuric Acid SCHEMBL16668789 | 0.94 | — | — | |
| Sulfuric Acid SCHEMBL28331475 | 0.94 | — | — | |
| Sulfuric Acid SCHEMBL29861157 | 0.94 | — | — | |
| Sulfuric Acid SCHEMBL28197345 | 0.89 | — | — | |
| Sulfuric Acid SCHEMBL3699224 | 0.87 | CA5A (1.00) | — | |
| Sulfuric Acid SCHEMBL8532128 | 0.87 | CA5A (1.00) | — | |
| Sulfuric Acid SCHEMBL2555505 | 0.87 | CA5A (1.00) | — | |
| Sulfuric Acid SCHEMBL418399 | 0.87 | CA5A (1.00) | — | |
| Sulfuric Acid SCHEMBL110268 | 0.87 | CA5A (1.00) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117510551-A | Pyridine sulfonamide iridium complex, preparation method and high-selectivity catalytic regeneration of NADH (NADH) | 烟台大学 | 2024-02-06 | — | — | CN | claimed |
| CN-110301441-A | The new application of chloroquine prevention and treatment root-knot nematode | 云南大学 | 2019-10-08 | — | — | CN | claimed |
| CN-117510551-A | Pyridine sulfonamide iridium complex, preparation method and high-selectivity catalytic regeneration of NADH (NADH) | 烟台大学 | 2024-02-06 | — | — | CN | disclosed |
| CN-114224890-A | Hydroxychloroquine sulfate pharmaceutical composition and preparation method thereof | 江苏知原药业股份有限公司 | 2022-03-25 | — | — | CN | disclosed |
| CN-106459827-B | Method for purifying a refined lipid phase | 德雷伊利林PVG有限责任两合公司 | 2020-12-08 | — | — | CN | disclosed |
| CN-109456266-A | The novel preparation method of hydroxychloroquine sulfate | 南京天际联盟医药科技有限公司 | 2019-03-12 | — | — | CN | disclosed |
| CN-109311929-A | SECO Macrocyclic lactone compounds | 菲德尔塔公司 | 2019-02-05 | — | — | CN | disclosed |
| CN-105250295-B | A kind of combination medicine and its application as immunomodulator | 广州中医药大学科技产业园有限公司 | 2018-12-25 | — | — | CN | disclosed |
| US-10053649-B2 | Method for purifying refined lipid phases | DREI LILIEN PVG GMBH & CO. KG (DE) | 2018-08-21 | — | — | US | disclosed |
| US-20170081611-A1 | METHOD FOR PURIFYING REFINED LIPID PHASES | DREI LILIEN PVG GMBH & CO. KG (DE) | 2017-03-23 | — | — | US | disclosed |